Market Cap 11.75M
Revenue (ttm) 0.00
Net Income (ttm) -11.08M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 104,000
Avg Vol 231,882
Day's Range N/A - N/A
Shares Out 10.31M
Stochastic %K 28%
Beta 1.93
Analysts Strong Buy
Price Target $15.00

Company Profile

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 538 8200
Fax: 609 452 6467
Address:
29 Emmons Drive, Suite B-10, Princeton, United States
BIO_keyIR
BIO_keyIR Apr. 10 at 7:38 PM
On TV tomorrow: BIO-key International $BKYI, 20/20 Biolabs $AIDX, Society Pass $SOPA, and Soligenix $SNGX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV. @BloombergTV #Redchip #SmallStocksBigMoneyShow
1 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 10 at 1:24 PM
🌅 Watchlist part 3 ✅ $LNKS mid 2.50 support, if above 3, have potential to 3.50/.80 ✅ $SQFT low 4 support, if above 4.50, have potential to 4.80/5.40 ✅ $IQST 2.10 support, if above 2.40, have potential to 2.60/2.70 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $ENLV $SNGX still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 10 at 1:23 PM
🌅 Watchlist part 2 ✅ $RAYA .80 support, if above 1, have potential to 1.20/1.50 ✅ $AIXI 1.20 support, if above 1.50, have potential to 1.66/1.80 ✅ $SAFX .60 support, if above .70, have potential to .80/.90 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $ENLV $SNGX still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 10 at 3:53 AM
🌅 Watchlist part 2 ✅ $IQST 2.40 support, if above 2.65, have potential to 2.80/3.30 ✅ $WORX 1/15 reverse split, new price ~1.64 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $ENLV $SNGX still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 9 at 2:34 AM
0 · Reply
Shodan84
Shodan84 Apr. 8 at 2:37 PM
0 · Reply
Kanile123
Kanile123 Apr. 8 at 11:30 AM
0 · Reply
ZacksSCR
ZacksSCR Apr. 6 at 8:01 PM
$SNGX: Interim Analysis for Phase 3 CTCL Study in 2Q26 https://buff.ly/pC0jrIG
0 · Reply
Merlintrader
Merlintrader Apr. 3 at 2:15 AM
$SNGX Soligenix (SNGX): HyBryte vs. Valchlor, the full story from the first comparison to today https://www.merlintrader.com/soligenix/
0 · Reply
NetworkNewsWire
NetworkNewsWire Apr. 2 at 3:01 PM
BioMedNewsBreaks — $SNGX Publishes Positive HyBryte Study Results In Oncology and Therapy https://ibn.fm/AxOgL
0 · Reply
Latest News on SNGX
Soligenix to Present at BIO Investment & Growth Summit

Feb 24, 2026, 7:30 AM EST - 6 weeks ago

Soligenix to Present at BIO Investment & Growth Summit


Soligenix Details Recent Progress and Upcoming Milestones

Feb 12, 2026, 7:30 AM EST - 2 months ago

Soligenix Details Recent Progress and Upcoming Milestones


Soligenix Announces Closing of $7.5 Million Public Offering

Sep 29, 2025, 4:05 PM EDT - 6 months ago

Soligenix Announces Closing of $7.5 Million Public Offering


Soligenix Announces Pricing of $7.5 Million Public Offering

Sep 26, 2025, 6:33 AM EDT - 7 months ago

Soligenix Announces Pricing of $7.5 Million Public Offering


Why Is Soligenix Stock Soaring On Monday?

Aug 18, 2025, 1:03 PM EDT - 8 months ago

Why Is Soligenix Stock Soaring On Monday?


IBN Initiates Coverage of Soligenix Inc.

Mar 25, 2025, 8:30 AM EDT - 1 year ago

IBN Initiates Coverage of Soligenix Inc.


Soligenix to Present at BIO CEO & Investor Conference

Feb 4, 2025, 7:30 AM EST - 1 year ago

Soligenix to Present at BIO CEO & Investor Conference


Soligenix to Present at Upcoming Investor Conferences

Jan 16, 2025, 7:30 AM EST - 1 year ago

Soligenix to Present at Upcoming Investor Conferences


Soligenix Invited to Present at Upcoming Investor Conferences

Oct 16, 2024, 7:30 AM EDT - 1 year ago

Soligenix Invited to Present at Upcoming Investor Conferences


BIO_keyIR
BIO_keyIR Apr. 10 at 7:38 PM
On TV tomorrow: BIO-key International $BKYI, 20/20 Biolabs $AIDX, Society Pass $SOPA, and Soligenix $SNGX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV. @BloombergTV #Redchip #SmallStocksBigMoneyShow
1 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 10 at 1:24 PM
🌅 Watchlist part 3 ✅ $LNKS mid 2.50 support, if above 3, have potential to 3.50/.80 ✅ $SQFT low 4 support, if above 4.50, have potential to 4.80/5.40 ✅ $IQST 2.10 support, if above 2.40, have potential to 2.60/2.70 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $ENLV $SNGX still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 10 at 1:23 PM
🌅 Watchlist part 2 ✅ $RAYA .80 support, if above 1, have potential to 1.20/1.50 ✅ $AIXI 1.20 support, if above 1.50, have potential to 1.66/1.80 ✅ $SAFX .60 support, if above .70, have potential to .80/.90 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $ENLV $SNGX still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Apr. 10 at 3:53 AM
🌅 Watchlist part 2 ✅ $IQST 2.40 support, if above 2.65, have potential to 2.80/3.30 ✅ $WORX 1/15 reverse split, new price ~1.64 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $ENLV $SNGX still in swing accumulation phase 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 9 at 2:34 AM
0 · Reply
Shodan84
Shodan84 Apr. 8 at 2:37 PM
0 · Reply
Kanile123
Kanile123 Apr. 8 at 11:30 AM
0 · Reply
ZacksSCR
ZacksSCR Apr. 6 at 8:01 PM
$SNGX: Interim Analysis for Phase 3 CTCL Study in 2Q26 https://buff.ly/pC0jrIG
0 · Reply
Merlintrader
Merlintrader Apr. 3 at 2:15 AM
$SNGX Soligenix (SNGX): HyBryte vs. Valchlor, the full story from the first comparison to today https://www.merlintrader.com/soligenix/
0 · Reply
NetworkNewsWire
NetworkNewsWire Apr. 2 at 3:01 PM
BioMedNewsBreaks — $SNGX Publishes Positive HyBryte Study Results In Oncology and Therapy https://ibn.fm/AxOgL
0 · Reply
DARKP00L
DARKP00L Apr. 2 at 11:50 AM
$SNGX 07:33 on Apr. 02 2026 Soligenix Announces Publication Of Comparability Study Results Evaluating HyBryte Versus Valchlor For Treatment Of Cutaneous T-Cell Lymphoma In Oncology And Therapy #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 2 at 11:31 AM
$SNGX Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
0 · Reply
NetworkNewsWire
NetworkNewsWire Mar. 31 at 7:47 PM
$SNGX Expands Pipeline Momentum as SGX945 Earns Global Recognition https://ibn.fm/3THHI
0 · Reply
NetworkNewsWire
NetworkNewsWire Mar. 31 at 6:28 PM
BioMedNewsBreaks – $SNGX Highlights Phase 3 CTCL Progress and Orphan Drug Milestones in 2025 Results https://ibn.fm/y9rOu
0 · Reply
GuruChartist
GuruChartist Mar. 31 at 1:30 PM
$HOTH $GOVX $SGNX Time to look for oversold small biotechs that have catalysts this year which will attract more investors and possible acquisition interest from the larger, well-capitalized biotechs/pharmas: Soligenix $SNGX -- rare-disease clinical stage biotech developing treatments for inflammatory diseases and infections. GeoVax Labs $GOVX--clinical-stage biotech developing multi-antigen vaccines and cancer immunotherapies. HOTH Therapeutics $HOTH -- biotech working on mRNA-based cancer and metabolic disease therapies. With any clinical news going into this Spring season of biotech and healthcare conferences can light a fire under these names. JMO
1 · Reply
RoyalsPalaceTrades
RoyalsPalaceTrades Mar. 31 at 4:28 AM
$SNGX been bullish since 2021
0 · Reply
Nmiller33
Nmiller33 Mar. 26 at 11:43 PM
$SNGX my 1.37 is fucked
1 · Reply
Slide3
Slide3 Mar. 26 at 8:42 PM
$SNGX Did they say anything new?
0 · Reply
sk7777777
sk7777777 Mar. 26 at 8:01 PM
0 · Reply
wesfabian1
wesfabian1 Mar. 26 at 7:46 PM
$SNGX not news it's history how bout some real pr Soligenix, Inc................starter
0 · Reply
Aldinho_lbk
Aldinho_lbk Mar. 26 at 7:24 PM
$SNGX USCLC presentation in Colorado is about to start... Heads up.
0 · Reply
sk7777777
sk7777777 Mar. 26 at 6:26 PM
$SNGX Today, tomorrow, next week... it's gonna climb.
0 · Reply